158 related articles for article (PubMed ID: 2951583)
1. Transient myeloproliferative disorder in chromosomally normal newborn infant.
Kalousek DK; Chan KW
Med Pediatr Oncol; 1987; 15(1):38-41. PubMed ID: 2951583
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the blast cell population in two neonates with Down's syndrome and transient myeloproliferative disorder.
Coulombel L; Derycke M; Villeval JL; Leonard C; Breton-Gorius J; Vial M; Bourgeois P; Tchernia G
Br J Haematol; 1987 May; 66(1):69-76. PubMed ID: 2954579
[TBL] [Abstract][Full Text] [Related]
3. Infants with Down's syndrome. Use of cytogenetic studies and in vitro colony assay for granulocyte progenitor to distinguish acute nonlymphocytic leukemia from a transient myeloproliferative disorder.
de Alarcon PA; Patil S; Golberg J; Allen JB; Shaw S
Cancer; 1987 Sep; 60(5):987-93. PubMed ID: 2955884
[TBL] [Abstract][Full Text] [Related]
4. Additional chromosome abnormalities in transient abnormal myelopoiesis in Down's syndrome patients.
Kounami S; Aoyagi N; Tsuno H; Suzuki H; Kitano N; Koike M
Acta Haematol; 1997; 98(2):109-12. PubMed ID: 9286308
[TBL] [Abstract][Full Text] [Related]
5. Congenital transient myeloproliferative disorder progressing to acute myeloid leukemia in Down's syndrome: a case report.
Prabhu PD; V G; Niveditha SR; Gayathri BR; Keshavamurthy SR
Indian J Pathol Microbiol; 2004 Jan; 47(1):48-50. PubMed ID: 15471129
[TBL] [Abstract][Full Text] [Related]
6. In vitro cell growth in neonates with Down's syndrome and transient myeloproliferative disorder.
Denegri JF; Rogers PC; Chan KW; Sadoway J; Thomas JW
Blood; 1981 Oct; 58(4):675-7. PubMed ID: 6456025
[TBL] [Abstract][Full Text] [Related]
7. Cytogenetic findings and clinical features in acute leukemia and transient myeloproliferative disorder in Down's syndrome.
Hayashi Y; Eguchi M; Sugita K; Nakazawa S; Sato T; Kojima S; Bessho F; Konishi S; Inaba T; Hanada R
Blood; 1988 Jul; 72(1):15-23. PubMed ID: 2968822
[TBL] [Abstract][Full Text] [Related]
8. Trisomy 21 in transient myeloproliferative disorder.
Faed MJ; Robertson J; Todd AS; Sivakumaran M; Tarnow-Mordi WO
Cancer Genet Cytogenet; 1990 Sep; 48(2):259-64. PubMed ID: 2144465
[TBL] [Abstract][Full Text] [Related]
9. Acute nonlymphocytic leukemia after transient myeloproliferative disorder in a patient with Down syndrome.
Barnett PL; Clark AC; Garson OM
Med Pediatr Oncol; 1990; 18(5):347-53. PubMed ID: 2142749
[TBL] [Abstract][Full Text] [Related]
10. Platelet peroxidase-positive blast cells in transient myeloproliferative disorder with Down's syndrome.
Suda J; Eguchi M; Ozawa T; Furukawa T; Hayashi Y; Kojima S; Maeda H; Tadokoro K; Sato Y; Miura Y
Br J Haematol; 1988 Feb; 68(2):181-7. PubMed ID: 2964860
[TBL] [Abstract][Full Text] [Related]
11. Test and teach. Number Seventy. Diagnosis: Transient myeloproliferative disorder in a child with Down's syndrome.
Wright SJ; Kerwick AM; Rodwell RL; Taylor KM
Pathology; 1993 Apr; 25(2):133, 207-8. PubMed ID: 8367191
[No Abstract] [Full Text] [Related]
12. Transient myeloproliferative disorder. In a neonate with Down syndrome. Immunophenotypic studies.
Cook JA; Raney B; Innes DJ; Normansell D
Clin Pediatr (Phila); 1989 Mar; 28(3):132-5. PubMed ID: 2522030
[TBL] [Abstract][Full Text] [Related]
13. Megakaryocytic phagocytosis in a chromosomally normal neonate with transient myeloproliferative disorder.
Lam TK; Prematilleke MN; Li CK; Fok TF
Acta Haematol; 1991; 86(1):49-50. PubMed ID: 1950364
[TBL] [Abstract][Full Text] [Related]
14. Transient myeloproliferative syndrome/transient acute myeloid leukemia in a newborn with Down syndrome: a case report and literature review.
D'Angelo G; Merlo P
Lab Hematol; 2003; 9(1):38-41. PubMed ID: 12661826
[TBL] [Abstract][Full Text] [Related]
15. Ultrastructural and ultracytochemical differences between transient myeloproliferative disorder and megakaryoblastic leukaemia in Down's syndrome.
Eguchi M; Sakaibara H; Suda J; Ozawa T; Hayashi Y; Sato T; Kojima S; Furukawa T
Br J Haematol; 1989 Nov; 73(3):315-22. PubMed ID: 2532535
[TBL] [Abstract][Full Text] [Related]
16. Transient leukemia (transient myeloproliferative disorder, transient abnormal myelopoiesis) of Down syndrome.
Brink DS
Adv Anat Pathol; 2006 Sep; 13(5):256-62. PubMed ID: 16998319
[TBL] [Abstract][Full Text] [Related]
17. Blast cell deficiency of CD11a as a marker of acute megakaryoblastic leukemia and transient myeloproliferative disease in children with and without Down syndrome.
Boztug H; Schumich A; Pötschger U; Mühlegger N; Kolenova A; Reinhardt K; Dworzak M
Cytometry B Clin Cytom; 2013; 84(6):370-8. PubMed ID: 23450818
[TBL] [Abstract][Full Text] [Related]
18. [Transient myeloproliferation and acute myeloid leukemia in infants with Down's syndrome].
Creutzig U; Ritter J; Vormoor J; Eschenbach C; Dickerhoff R; Burdach S; Scheel-Walter HG; Kühl J; Schellong G
Klin Padiatr; 1990; 202(4):253-7. PubMed ID: 2144325
[TBL] [Abstract][Full Text] [Related]
19. [Congenital leukaemia and transient myeloproliferative disorder: diagnostic difficulties--case reports].
Jackowska T; Steczowicz M; Pawelec K; Pacholska J
Med Wieku Rozwoj; 2006; 10(3 Pt 1):595-601. PubMed ID: 17317890
[TBL] [Abstract][Full Text] [Related]
20. Leukemia and/or myeloproliferative syndrome in neonates with Down syndrome.
Zipursky A; Brown E; Christensen H; Sutherland R; Doyle J
Semin Perinatol; 1997 Feb; 21(1):97-101. PubMed ID: 9190039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
